UniProtKB/SwissProt variant VAR

Variant information

Variant position:

97

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Asparagine (N) to Aspartate (D) at position 97 (N97D, p.Asn97Asp).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and polar (N) to medium size and acidic (D)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In obesity; completely unable to generate cAMP in response to ligand; shows evidence of impaired cell surface expression.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs121913565 [ dbSNP | Ensembl ]

Sequence information

Variant position:

97

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

332

The length of the canonical sequence.

Location on the sequence:

SPMYFFICSLAVADMLVSVS N GSETIVITLLNSTDTDAQSF

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SPMYFFICSLAVADMLVSVSNGSETIVITLLNSTD-TDAQSF

Mouse                         SPMYFFICSLAVADMLVSVSNGSETIVITLLNSTD-TDAQS

Rat                           SPMYFFICSLAVADMLVSVSNGSETIVITLLNSTD-TDAQS

Pig                           SPMYFFICSLAVADMLVSVSNGSETIVITLLNSTD-TDAQS

Bovine                        SPMYFFICSLAVADMLVSVSNGSETIVITLLNSTD-TDAQS

Zebrafish                     SPMYFFICSLAVADLLVSVSNASETVVMALITGGNLTNRES

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 332	Melanocortin receptor 4
Transmembrane	82 – 106	Helical; Name=2
Disulfide bond	84 – 84	Interchain
Helix	78 – 106

Literature citations

Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.
Yeo G.S.H.; Lank E.J.; Farooqi I.S.; Keogh J.; Challis B.G.; O'Rahilly S.;
Hum. Mol. Genet. 12:561-574(2003)
Cited for: VARIANTS OBESITY SER-62; ASP-97; PRO-106; LYS-125; GLN-165; THR-175; ILE-253; TYR-271 AND SER-316; CHARACTERIZATION OF VARIANTS OBESITY SER-62; ASP-97; PRO-106; LYS-125; GLN-165; THR-175; ILE-253; TYR-271 AND SER-316;

Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.
Farooqi I.S.; Keogh J.M.; Yeo G.S.H.; Lank E.J.; Cheetham T.; O'Rahilly S.;
N. Engl. J. Med. 348:1085-1095(2003)
Cited for: VARIANTS OBESITY ALA-11; SER-62; ASP-97; LYS-125; GLN-165; THR-175; TYR-271; ARG-271 AND SER-316; VARIANTS ILE-103; MET-112 AND LEU-251; CHARACTERIZATION OF VARIANTS OBESITY ALA-11; SER-62; ASP-97; LYS-125; GLN-165; THR-175; TYR-271 AND SER-316; CHARACTERIZATION OF VARIANTS ILE-103; MET-112 AND LEU-251; FUNCTION;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P32245: Variant p.Asn97Asp